Acetazolamide improves action myoclonus in Ramsay Hunt syndrome
Vaamonde J, Legarda I, Jimenez-Jimenez J, Obeso JA.
Department of Neurology, Clinica Universitaria, Madrid, Spain.
Magazine: Clinical Neuropharmacology
Date: Sep 30, 1992Neurology [SP]
The myoclonus of two patients with Ramsay Hunt syndrome was only partially controlled under treatment with clonazepam, sodium valproate, primidone, and piracetam. Acetazolamide (200 mg daily) was added to these drugs, resulting in a dramatic improvement. Placebo substitution (one patient) and withdrawal of acetazolamide in the other patient resulted in marked aggravation of the myoclonus. The mechanism of action of acetazolamide in myoclonus is unknown.
Acetazolamide may be an additional therapeutic possibility for patients with severe action myoclonus.
CITATION Clin Neuropharmacol. 1992 Oct;15(5):392-6
you mayBE INTERESTED
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.